| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/02/2013 | CN102847141A Oral formulations for enteric disorders and/or rehydration |
| 01/02/2013 | CN102846996A Compound lycium barbarum herbal tea or granular preparation for relieving summer-heat, slaking thirst, helping produce saliva and moistening lungs |
| 01/02/2013 | CN102846955A Chinese herbal medicine heightening insole |
| 01/02/2013 | CN102846927A Chinese medicine prescription for treatment of postpartum spontaneous perspiration |
| 01/02/2013 | CN102846921A Hardness softening and stagnation dissipating algal tablet |
| 01/02/2013 | CN102846878A Preparation technology and production method for an integrated new formulation of angelica peony wine |
| 01/02/2013 | CN102846796A Medicinal composition for treating postpartum night sweat and preparation method thereof |
| 01/02/2013 | CN102846670A Biological medicament for treating finger biting addiction |
| 01/02/2013 | CN102174520B Interference nucleic acid molecule and application thereof |
| 01/02/2013 | CN102146411B Novel bifunctional cicatrix and tissue fibrosis resistant oligonucleotide medicament |
| 01/02/2013 | CN102088871B Nutritional composition containing oligosaccharide mixture |
| 01/02/2013 | CN101948859B shRNA expression vector expressed by specificity inhibitor SET protein, construction method and application thereof |
| 01/02/2013 | CN101909586B External skin preparation for pimpled skin |
| 01/02/2013 | CN101830889B 嘧啶衍生物 Pyrimidine derivatives |
| 01/02/2013 | CN101799476B Reagent box for sieving autoantibody for tsh receptor |
| 01/02/2013 | CN101747321B Indole-3-benzylamine derivative, preparation method and application |
| 01/02/2013 | CN101677931B Wrinkling-preventing and -modifying agent |
| 01/02/2013 | CN101671388B Blood brain barrier penetrable erythropoietin (EPO) and application thereof |
| 01/02/2013 | CN101631794B Oligosaccharides comprising an aminooxy group and conjugates thereof |
| 01/02/2013 | CN101410124B Thioredoxin production promoting agent |
| 01/01/2013 | US8344110 Antibodies to thymic stromal lymphopoietin (TSLP) receptor molecules and uses thereof |
| 01/01/2013 | US8344003 2-pyridinecarboxamide derivatives |
| 01/01/2013 | US8343988 Inhibitors of histone deacetylase |
| 01/01/2013 | US8343979 Use of alkanoyl L-carnitine for the treatment of erectile dysfunction |
| 01/01/2013 | US8343937 Methods and compositions for treating flaviviruses and pestiviruses |
| 01/01/2013 | US8343550 Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus |
| 01/01/2013 | US8343549 Therapeutic uses of Dunaliella powder |
| 01/01/2013 | US8343544 Oral sustained-release tablet |
| 01/01/2013 | US8343543 Lipase inhibiting composition |
| 01/01/2013 | US8343492 Method for blocking binding of CX3C chemokines using CX3C chemokine antibodies |
| 12/27/2012 | WO2012177842A1 Fast dissolving azaperone granulate formulation |
| 12/27/2012 | WO2012177211A1 Activated carbon and iodine/iodine salts for treating chronic fatigue syndrome |
| 12/27/2012 | WO2012176804A1 Glucopyranosyloxypyrazole derivative |
| 12/27/2012 | WO2012176765A1 Anti-human p-cadherin (cdh3) recombinant antibody |
| 12/27/2012 | WO2012176763A1 Novel indazole derivative |
| 12/27/2012 | WO2012176438A1 Sedative agent for vaporization and inhalation, and sedative perfume composition containing same |
| 12/27/2012 | WO2012176282A1 Apoptosis-inducing agent |
| 12/27/2012 | WO2012174730A1 Preparative method and use of zyj-d08a and its epimers as histone deacetylase inhibitors |
| 12/27/2012 | WO2012123965A3 Potentised coagulant dose generator |
| 12/27/2012 | US20120330019 Hepatitis C Virus Inhibitors |
| 12/27/2012 | US20120329990 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 12/27/2012 | US20120329863 Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia |
| 12/27/2012 | US20120329862 Novel compound having inhibitory effect on lipase |
| 12/27/2012 | US20120329844 Valsartan salts |
| 12/27/2012 | US20120329834 Compounds for the treatment of mitochondrial diseases |
| 12/27/2012 | US20120329820 Pyridinoylpiperidines As 5-HT1F Agonists |
| 12/27/2012 | US20120329796 Compounds useful for treating premature aging and in particular progeria |
| 12/27/2012 | US20120329729 Methods for treating diabetic foot ulcers |
| 12/27/2012 | US20120329715 Glp-1, exendin-4, peptide analogs and uses thereof |
| 12/27/2012 | US20120329063 Novel means for the diagnosis and therapy of ctcl |
| 12/27/2012 | US20120329052 Identification of a dna variant associated with adult type hypolactasia |
| 12/27/2012 | US20120328720 Iridoid Based Formulations |
| 12/27/2012 | US20120328679 Solid pharmaceutical dispersions with enhanced bioavailability |
| 12/27/2012 | US20120328669 High density fibrous polymers suitable for implant |
| 12/27/2012 | US20120328632 Inhibition of leukocyte adhesion |
| 12/27/2012 | US20120328567 Biomarkers predictive of therapeutic responsiveness to ifnb and uses thereof |
| 12/27/2012 | US20120328517 Kallikrein-binding "kunitz domain" proteins and analogues thereof |
| 12/27/2012 | CA2841203A1 Apoptosis-inducing agent |
| 12/27/2012 | CA2836497A1 Fast dissolving azaperone granulate formulation |
| 12/26/2012 | EP2537831A1 Imidazole derivative |
| 12/26/2012 | EP2537422A1 Lifespan extending agent |
| 12/26/2012 | CN1816536B Regulator of cannabinoid receptor |
| 12/26/2012 | CN102844436A Aptamer for ngf and use thereof |
| 12/26/2012 | CN102844320A 杂环化合物 Heterocyclic Compounds |
| 12/26/2012 | CN102844290A 1-(2-fluorobiphenyl-4-yl)-alkyl carboxylic acid derivatives for the therapy of transthyretin amyloidosis |
| 12/26/2012 | CN102844048A Pharmaceutical agent for treatment and/or prevention of cancer |
| 12/26/2012 | CN102844038A Mixture, dissolving solution and pharmaceutical agent each comprising thermophilic microorganism |
| 12/26/2012 | CN102839206A Preparation method for promoting self generation of human bone marrow hematopoietic stem cells |
| 12/26/2012 | CN102839096A Summer-heat relieving talc health wine |
| 12/26/2012 | CN102839092A Heat-clearing and detoxifying honeysuckle flower health-care wine |
| 12/26/2012 | CN102838658A Treatment of inflammation and/or endotoxic shock |
| 12/26/2012 | CN102838596A Pyrrolo[2,3-b]pyridine derivative, preparation method and application thereof |
| 12/26/2012 | CN102836422A Disease prevention and growth promotion magic drug |
| 12/26/2012 | CN102836267A Traditional Chinese drug oral liquid for treating children night sweat |
| 12/26/2012 | CN102836183A Lucid ganoderma detoxification traditional Chinese drug composition and preparation method thereof |
| 12/26/2012 | CN102836140A Arctigenin micro-emulsion enteric soft capsule preparation |
| 12/26/2012 | CN102836119A Utilization of microvesicle in preparation of medicine used for joint diagnosis level ultrasound as improvement of tumor capillary permeability |
| 12/26/2012 | CN102049034B Hoof nail polypeptide preparation for promoting tissue repair and preparation method thereof |
| 12/26/2012 | CN102038638B 盐酸克林霉素注射液及其制备方法 Clindamycin Hydrochloride Injection and its preparation method |
| 12/26/2012 | CN101820874B Powdered medicament for nasal delivery of ascorbic acid for reducing apomorphine induced toxicity to ciliated tissue |
| 12/26/2012 | CN101677983B Composition useful for the prevention of adverse effect due to the use of ppar-gamma agonists |
| 12/26/2012 | CN101633623B Method for extracting mulberry leaf gamma-aminobutyric acid and application thereof |
| 12/26/2012 | CN101495630B Gene involved in immortalization of human cancer cell and use thereof |
| 12/26/2012 | CN101439181B Stable water injection medicament composition containing Ulinastatin |
| 12/26/2012 | CN101210051B Anti-VEGF antibodies |
| 12/26/2012 | CN101076521B Process for producing muscarine receptor antagonist and intermediate therefor |
| 12/25/2012 | US8338478 Derivatives of 3,3-diphenylpropylamines |
| 12/25/2012 | US8338429 2-acylaminothiazole derivative or salt thereof |
| 12/25/2012 | US8338384 Method for treating ocular neovascularization |
| 12/25/2012 | US8338168 Chimeric glycoproteins and pseudotyped lentiviral vectors |
| 12/25/2012 | US8338150 Method for combined parallel agent delivery and electroporation for cell structures an use thereof |
| 12/25/2012 | US8337915 Fenugreek seed extract to lower blood cholesterol |
| 12/25/2012 | US8337901 Process for the manufacture of cellulose sulfate with improved characteristics |
| 12/25/2012 | US8337899 Solid pharmaceutical dispersions with enhanced bioavailability |
| 12/25/2012 | US8337833 Methods of improving central nervous system functioning |
| 12/25/2012 | US8337829 Conditioned medium and proliferated cell lines produced therefrom |
| 12/20/2012 | WO2012174522A1 Combined chemical modification of sphingosine-1-phosphate (s1p) and cxcr4 signalling pathways for hematopoietic stem cell (hsc) mobilization and engraftment |
| 12/20/2012 | WO2012174049A2 Compositions and methods for controlling neuronal excitation |
| 12/20/2012 | WO2012173219A1 Novel biaryl ether derivative |
| 12/20/2012 | WO2012173217A1 Crystal of pyrroloquinolinequinone disodium salt, and method for producing same |